These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 723886)

  • 1. Selective analysis of adenosine, 1-methylinosine and N2-methylguanosine by high pressure liquid chromatography.
    Brown PR; Krstulović AM; Hartwick RA
    Monogr Hum Genet; 1978; 10():135-40. PubMed ID: 723886
    [No Abstract]   [Full Text] [Related]  

  • 2. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High performance liquid chromatographic determination of serum UV profiles of normal subjects and patients with breast cancer and benign fibrocystic changes.
    Krstulovic AM; Hartwick RA; Brown PR
    Clin Chim Acta; 1979 Oct; 97(2-3):159-70. PubMed ID: 487602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some clinical and pharmacological applications of high-speed liquid chromatography.
    Nelson JA
    Adv Chromatogr; 1977; 15():273-305. PubMed ID: 320837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Dudley E; Lemière F; Van Dongen W; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2004; 18(22):2730-8. PubMed ID: 15499664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
    Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
    J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.
    Tormey DC; Waalkes TP; Ahmann D; Gehrke CW; Zumwatt RW; Snyder J; Hansen H
    Cancer; 1975 Apr; 35(4):1095-100. PubMed ID: 1116102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective characterisation of N1-methyladenosine and N7-methylguanosine in urine (author's transl)].
    Schlimme E; Boos KS; Weise M
    J Clin Chem Clin Biochem; 1981 Feb; 19(2):55-60. PubMed ID: 7217895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 8-diamino-substituted adenosine, inosine, and guanosine.
    Mauriņs JA; Zariņa DzE; Paegle RA; Lĩdaks MJ
    Nucleic Acids Symp Ser; 1989; (21):41-2. PubMed ID: 2608471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of inosine and adenosine in human plasma using high-performance liquid chromatography and a boronate affinity gel.
    Pfadenhauer EH; Tong SD
    J Chromatogr; 1979 Apr; 162(4):585-90. PubMed ID: 528669
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple high-performance liquid chromatography assay for simultaneous measurement of adenosine, guanosine, and the oxypurine metabolites in plasma.
    Feng JD; Yeung PK
    Ther Drug Monit; 2000 Apr; 22(2):177-83. PubMed ID: 10774630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine metabolism in vivo.
    Zhang YL; Li T; Lautt WW
    Proc West Pharmacol Soc; 1994; 37():15-6. PubMed ID: 7984651
    [No Abstract]   [Full Text] [Related]  

  • 13. Dipyridamole and 8-aminoguanosine inhibition of nucleoside metabolism in rat blood in vitro.
    Gilbertsen RB; Dong MK
    Adv Exp Med Biol; 1986; 195 Pt A():575-82. PubMed ID: 3088923
    [No Abstract]   [Full Text] [Related]  

  • 14. Incorporation of purine analogs into the nucleotide pools of human erythrocytes.
    Parks RE; Brown PR; Kong CM
    Adv Exp Med Biol; 1973; 41():117-27. PubMed ID: 4791189
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective analysis for adenosine using reversed-phase high-pressure liquid chromatography.
    Hartwick RA; Brown PR
    J Chromatogr; 1977 Jul; 143(4):383-9. PubMed ID: 885977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescing Isofunctional Ribonucleosides: Assessing Adenosine Deaminase Activity and Inhibition.
    Ludford PT; Rovira AR; Fin A; Tor Y
    Chembiochem; 2019 Mar; 20(5):718-726. PubMed ID: 30566279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC; Waalkes TP; Gehrke CW
    J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC analysis of aromatic amino acids, nucleosides, and bases in plasma of acute lymphocytic leukemia on chemotherapy.
    Zakaria M; Brown PR; Farnes MP; Barker BE
    Clin Chim Acta; 1982 Nov; 126(1):69-80. PubMed ID: 6959747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of adenosine deaminase isoforms by HPLC.
    Roberts EL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):334. PubMed ID: 16330263
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA; Grever MR; Speicher CE; Trewyn RW
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.